Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.17M Buy
22,737
+4,604
+25% +$848K 0.3% 71
2025
Q4
$3.19M Buy
18,133
+21
+0.1% +$3.43K 0.23% 79
2025
Q3
$2.54M Sell
18,112
-11
-0.1% -$1.49K 0.33% 60
2025
Q2
$2.28M Buy
18,123
+288
+2% +$35.9K 0.18% 102
2025
Q1
$2.44M Buy
17,835
+3,903
+28% +$558K 0.35% 58
2024
Q4
$2.13M Sell
13,932
-7
-0.1% -$1.18K 0.19% 92
2024
Q3
$2.7M Sell
13,939
-17
-0.1% -$3.56K 0.25% 69
2024
Q2
$3.24M Buy
13,956
+104
+0.8% +$22.6K 0.33% 56
2024
Q1
$2.99M Buy
13,852
+5,098
+58% +$1.19M 0.31% 59
2023
Q4
$2.26M Buy
+8,754
New +$2.15M 0.23% 75

Other funds holding BIIB

Leo Wealth LLC's BIIB Position: Q1 2026 in Review

Leo Wealth LLC increased its Biogen (BIIB) stake by 25% in Q1 2026, buying an estimated $848K and bringing the position to 22,737 shares worth $4.17M. The position accounts for 0.3% of the portfolio, ranked #71.

Leo Wealth LLC first reported a position in BIIB in Q4 2023 and has held it in 10 quarters since. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Leo Wealth LLC held 22,737 shares of Biogen worth $4.17M as of Q1 2026.
  • Leo Wealth LLC bought 4,604 Biogen shares in Q1 2026, an estimated $848K.
  • Biogen made up 0.3% of Leo Wealth LLC's portfolio in Q1 2026, its #71 holding.
  • Leo Wealth LLC first reported a position in Biogen in Q4 2023 and has held it in 10 quarters since.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.